FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to pharmacology and medicine. Invention describes microparticles, including cyclo[{4-(NH2-C2H4-NH-CO-O-)Pro}-Phg-DTrp-Lys-Tyr(4-Bzl)-Phe] in free form, submerged into bio-compatible pharmacologically acceptable polymer matrix, where polymer matrix contains at least two different polymers selected from the group including linear and branched polylactide-co-glycolide for continuous release, and pharmaceutical compositions, including such microparticles.
EFFECT: production of pharmaceutical compositions, including microparticles - analogs of somatostatin.
13 cl, 11 ex, 4 tbl
Authors
Dates
2010-11-27—Published
2004-11-12—Filed